Nanostics Inc.
PrivateLast Round
Grant
Jun 26, 2025
Total Funding Raised
$4.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nanostics Inc. is a biotechnology company that develops and commercializes non-invasive diagnostic tests using its ClarityDX® platform, which employs machine learning to generate risk scores for various diseases including prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanostics Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nanostics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 26, 2025 | ||||
| VC Round | Apr 23, 2024 | ||||
| Grant | May 1, 2023 | ||||
| Grant | May 28, 2018 |
Key People
Founding team and executive leadership
Nanostics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genome Alberta | Grant |
| Alberta Cancer Foundation | Grant |
| Alberta Innovates | Grant |
| Genome Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 630% MoM to 11.7K.
- Oct 28, 2025
Expanding offices to Middle, New Jersey for US market entry.
Nanostics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanostics Inc.'s valuation, stock price, and market status.